Delivery Order SPE2DB24D2205-SPE2DB24FDWXV

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of cefpodoxime 200 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,437.70, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a completion date of March 7, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Cefpodoxime 200 mg tablets. The contract, valued at $1,096.35, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 21, 2024 with a completion date of June 24, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Cefpodoxime 100 mg tablets to the Defense Logistics Agency (DLA). The $1,198.85 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Cefpodoxime 200 mg Tablets in quantities of 20s. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,563.58 and a completion date of September 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Cefpodoxime 200 mg tablets, a prescription medication, with a ceiling value of $1,328.26 and a period of performance through August 8, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,374.36 firm-fixed-price delivery order is for the supply of Cefpodoxime 100 mg tablets. The contract has an ultimate completion date of July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefpodoxime 200 mg tablets. The contract has a firm fixed price of $6,967.65 and a completion date of September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefpodoxime 200 mg tablets. The contract has a firm fixed price of $2,116.42 and an ultimate completion date of June 25, 2024. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cefpodoxime 100 mg/5 ml suspension, a generic pharmaceutical product. The contract has a ceiling value of $10,874.32 and a completion date of September 20, 2023. This appears to be a delivery order contract, with a firm fixed price pricing type. The contract is not designated as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $4,119.18 firm fixed-price contract is for the delivery of Cefpodoxime 200 mg tablets to support military treatment programs and facilities. The award is not associated with any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWXV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cefpodoxime 200 mg tablets. The contract has a firm fixed price of $1,196.86 and a performance period through July 17, 2024. This is a delivery order contract and does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by DLA and other agencies to supply a wide range of essential pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other government healthcare programs. The company's extensive supply chain and distribution capabilities enable it to reliably deliver critical medical commodities to various federal customers.

Generated 10/15/24, 9:31 PM